Jae Jong Kim

USPTO Granted Patents = 4 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 4.4

ph-index = 1

Company Filing History:

Intron Biotechnology, Inc.

Samyang Biopharmaceuticals Corporation

patents

where one patent can have more than one assignee

Years Active: 2012-2019

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10337052 - Method for testing a mutant gene through real time polymerase chain reaction using inhibition of 5'-flap endonuclease activity (2019-07-02),

2. 9505779 - Tacrolimus analogues, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same (2016-11-29),

3. 8609368 - Process for purifying vancomycin wet body (2013-12-17),

4. 8193345 - Purification method of lactone compounds containing unsaturated alkyl group by extraction with silver ion solution (2012-06-05),

Title: Jae Jong Kim: Innovator in Genetic Testing and Neuroprotective Compositions

Introduction

Jae Jong Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the fields of genetic testing and neuroprotective compositions. With a total of 4 patents to his name, Kim's work has the potential to impact both medical diagnostics and therapeutic treatments.

Latest Patents

One of Kim's latest patents is a method for testing a mutant gene through real-time polymerase chain reaction (PCR) using inhibition of 5'-flap endonuclease activity. This innovative method allows for the detection of single nucleotide polymorphisms (SNPs) by utilizing the unique feature that the 5'-flap endonuclease activity of DNA polymerase is inhibited when a probe binds to the end of a PCR product. This design enables effective SNP detection, particularly when the SNP site is located at the 5'-end of the probe.

Another notable patent involves tacrolimus analogues, which are neuroprotective compositions aimed at preventing or treating neurological diseases and immune hypersensitivity disorders. This invention includes a method for preparing these analogs using an isolated modified strain, where the activity of specific enzymes is reduced. The potential applications of these analogs could lead to advancements in treating various medical conditions.

Career Highlights

Throughout his career, Jae Jong Kim has worked with reputable companies such as Genotech Corp. and Intron Biotechnology, Inc. His experience in these organizations has contributed to his expertise in the development of innovative solutions in biotechnology.

Collaborations

Kim has collaborated with notable colleagues, including Si Kyu Lim and Sun Ho Cha. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented technologies.

Conclusion

Jae Jong Kim is a distinguished inventor whose work in genetic testing and neuroprotective compositions showcases his innovative spirit and dedication to advancing medical science. His contributions are poised to make a lasting impact in the fields of genetics and neurology.

This text is generated by artificial intelligence and may not be accurate.